ResearcherUniversity of CopenhagenActive in the last 2 years

Mads Hald Andersen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2914-9605; OpenAlex author ID A5026885591. Sources: OpenAlex.

Their work

Papers: 4 (first author 0, last author 3)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 9

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 4

Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. Co-author DOI 10.1002/iid3.70545 ↗
Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates. Last author DOI 10.1038/s41392-026-02626-3 ↗
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy. Last author DOI 10.1136/jitc-2022-006432 ↗
TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer. Last author DOI 10.1136/jitc-2022-005491 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Susann Theile · 2 shared papers, 2026 · strength 0.63
- Paper Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. DOI 10.1002/iid3.70545 ↗
- Paper Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates. DOI 10.1038/s41392-026-02626-3 ↗
Julia Sidenius Johansen · 2 shared papers, 2023–2026 · strength 0.50
- Paper Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. DOI 10.1002/iid3.70545 ↗
- Paper Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhib… DOI 10.1136/jitc-2022-006432 ↗
Rasmus Erik Johansson Mortensen · 2 shared papers, 2023–2026 · strength 0.47
- Paper Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates. DOI 10.1038/s41392-026-02626-3 ↗
- Paper Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhib… DOI 10.1136/jitc-2022-006432 ↗
Inna Markovna Chen · 2 shared papers, 2023–2026 · strength 0.47
- Paper Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates. DOI 10.1038/s41392-026-02626-3 ↗
- Paper Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhib… DOI 10.1136/jitc-2022-006432 ↗
Inna M. Chen · 1 shared paper, 2026 · strength 0.33
- Paper Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. DOI 10.1002/iid3.70545 ↗
Laura Kofoed Kjær · 1 shared paper, 2026 · strength 0.33
- Paper Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. DOI 10.1002/iid3.70545 ↗
Josephine Hallundbæk Ruders · 1 shared paper, 2026 · strength 0.30
- Paper Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates. DOI 10.1038/s41392-026-02626-3 ↗
Dorte Lisbet Nielsen · 1 shared paper, 2023 · strength 0.17
- Paper Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhib… DOI 10.1136/jitc-2022-006432 ↗
Maria Perez-Penco · 1 shared paper, 2022 · strength 0.13
- Paper TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine… DOI 10.1136/jitc-2022-005491 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.